approved ONAPGO (apomorphine hydrochloride) injection, formerly known as SPN-830, as the first and only subcutaneous apomorphine infusion device for the treatment of motor fluctuations in adults ...
Hosted on MSN1mon
Huntsville biotech firm partnering with Pfizer lands $10 million for Parkinson’s trialThe proposed treatment combines the company’s technology with a wearable device from Enable Injections, for ease of administration. The system aims to deliver apomorphine in a way that could ...
Supernus Pharmaceuticals Stock Falls On Disappointing Data From Treatment-Resistant Depression Trial
Earlier this month, the FDA approved Supernus Pharmaceuticals’ ONAPGO (apomorphine hydrochloride) injection, formerly known as SPN-830, as the first and only subcutaneous apomorphine infusion ...
Serina Therapeutics, Inc. ("Serina") (NYSE American: SER), a clinical-stage biotechnology company developing its proprietary POZ Platform drug optimization ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback